These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35233832)

  • 1. Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity.
    Liu T; Li J; Deng Z; Chen M; Sha K; Xiao W; Xie H; Zhao Z
    J Dermatol; 2022 May; 49(5):525-533. PubMed ID: 35233832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigate circulating levels of chemokines and evaluate the correlation between these chemokines and liver function indicators in autoimmune hepatitis].
    Li YL; Liu N; Zhao DT; Li ZM; Zhang HP; Liu YM; Yan HP; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):299-303. PubMed ID: 24021794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees.
    Bonfante HL; Almeida CS; Abramo C; Grunewald STF; Levy RA; Teixeira HC
    Int J Rheum Dis; 2017 Dec; 20(12):1958-1964. PubMed ID: 25955863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
    Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
    Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.
    Eck M; Schmausser B; Scheller K; Brändlein S; Müller-Hermelink HK
    Clin Exp Immunol; 2003 Dec; 134(3):508-15. PubMed ID: 14632759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
    Wimer CL; Damiani A; Osterrieder N; Wagner B
    Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
    Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis].
    Zhong H; Xu LL; Bai MX; Su Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1026-1031. PubMed ID: 34916676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis.
    Kuan WP; Tam LS; Wong CK; Ko FW; Li T; Zhu T; Li EK
    J Rheumatol; 2010 Feb; 37(2):257-64. PubMed ID: 20032101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata.
    Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A
    Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-inducible chemokines reflect severity and progression in sarcoidosis.
    Su R; Nguyen ML; Agarwal MR; Kirby C; Nguyen CP; Ramstein J; Darnell EP; Gomez AD; Ho M; Woodruff PG; Koth LL
    Respir Res; 2013 Nov; 14(1):121. PubMed ID: 24199653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
    Menke J; Zeller GC; Kikawada E; Means TK; Huang XR; Lan HY; Lu B; Farber J; Luster AD; Kelley VR
    J Am Soc Nephrol; 2008 Jun; 19(6):1177-89. PubMed ID: 18337479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chemokines and the corresponding receptors in vitiligo: A pilot study.
    Yang L; Yang S; Lei J; Hu W; Chen R; Lin F; Xu AE
    J Dermatol; 2018 Jan; 45(1):31-38. PubMed ID: 29115683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
    Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
    Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis.
    Rabquer BJ; Tsou PS; Hou Y; Thirunavukkarasu E; Haines GK; Impens AJ; Phillips K; Kahaleh B; Seibold JR; Koch AE
    Arthritis Res Ther; 2011 Feb; 13(1):R18. PubMed ID: 21303517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory chemokines and their receptors in human visceral leishmaniasis: Gene expression profile in peripheral blood, splenic cellular sources and their impact on trafficking of inflammatory cells.
    Singh N; Sundar S
    Mol Immunol; 2017 May; 85():111-119. PubMed ID: 28222329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
    Müllegger RR; Means TK; Shin JJ; Lee M; Jones KL; Glickstein LJ; Luster AD; Steere AC
    Infect Immun; 2007 Sep; 75(9):4621-8. PubMed ID: 17606602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study.
    Stanisic M; Lyngstadaas SP; Pripp AH; Aasen AO; Lindegaard KF; Ivanovic J; Ilstad E; Konglund A; Sandell T; Ellingsen O; Saehle T
    Acta Neurochir (Wien); 2012 Jan; 154(1):113-20; discussion 120. PubMed ID: 22037980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL9 and CXCL10 are differentially associated with systemic organ involvement and pulmonary disease severity in sarcoidosis.
    Arger NK; Ho ME; Allen IE; Benn BS; Woodruff PG; Koth LL
    Respir Med; 2020 Jan; 161():105822. PubMed ID: 31783271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.
    Altara R; Manca M; Hessel MH; Gu Y; van Vark LC; Akkerhuis KM; Staessen JA; Struijker-Boudier HA; Booz GW; Blankesteijn WM
    J Cardiovasc Transl Res; 2016 Aug; 9(4):302-14. PubMed ID: 27271043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.